| 14.07.2023 08:36 | AGY | Form 8.5 (EPT/RI) | RNS |
| 13.07.2023 08:23 | AGY | Form 8.5 (EPT/RI) | RNS |
| 12.07.2023 08:44 | AGY | Form 8.5 (EPT/RI) | RNS |
| 11.07.2023 08:15 | AGY | Form 8.5 (EPT/RI) | RNS |
| 10.07.2023 13:45 | LGEN, AGY | Allergy Therapeutics appoints new CFO; interim CFO to leave in August | Alliance |
| 10.07.2023 13:12 | AGY | Appointment of Chief Financial Officer | RNS |
| 10.07.2023 08:33 | AGY | Form 8.5 (EPT/RI) | RNS |
| 07.07.2023 08:28 | AGY | Form 8.5 (EPT/RI) | RNS |
| 06.07.2023 08:20 | AGY | Form 8.5 (EPT/RI) | RNS |
| 05.07.2023 08:45 | AGY | Form 8.5 (EPT/RI) | RNS |
| 04.07.2023 08:35 | AGY | Form 8.5 (EPT/RI) - Allergy Therapeutics PLC | RNS |
| 03.07.2023 09:39 | AGY | Form 8.5 (EPT/RI) | RNS |
| 30.06.2023 12:08 | AGY | Form 8.5 (EPT/RI) | RNS |
| 29.06.2023 08:31 | AGY | Form 8.5 (EPT/RI) | RNS |
| 28.06.2023 16:39 | AGY | Form 8.5 (EPT/RI) | RNS |
| 28.06.2023 16:08 | AGY | Form 8.5 (EPT/RI) - Allergy Therapeutics PLC | RNS |
| 28.06.2023 08:32 | AGY | Form 8.5 (EPT/RI) | RNS |
| 26.06.2023 09:25 | AGY | Form 8.5 (EPT/RI) | RNS |
| 23.06.2023 11:48 | AGY | Form 8.5 (EPT/RI) | RNS |
| 22.06.2023 08:45 | AGY | Form 8.5 (EPT/RI) | RNS |
| 21.06.2023 09:38 | AGY | Form 8.5 (EPT/RI) | RNS |
| 20.06.2023 12:49 | AGY | Form 8.5 - Allergy Therapeutics plc | RNS |
| 20.06.2023 09:05 | AGY | Form 8.5 (EPT/RI) | RNS |
| 19.06.2023 11:40 | AGY | Allergy Therapeutics banks on second half-year to boost revenue | Alliance |
| 19.06.2023 07:30 | AGY | Restoration - Allergy Therapeutics PLC | RNS |
| 19.06.2023 07:01 | AGY | Interim Results and Lifting Suspension in Trading | RNS |
| 19.06.2023 07:00 | AGY | Publication of Annual Report and Accounts 2022 | RNS |
| 09.06.2023 07:00 | AGY | Allergy Therapeutics shares key findings at EAACI | Reach |
| 03.05.2023 09:09 | AGY, GSK | Form 8.3 - Allergy Therapeutics plc | RNS |
| 27.04.2023 14:15 | AGY | Result of General Meeting | RNS |
| 24.04.2023 07:00 | AGY | Southern Fox: Form 8.3 – Allergy Therapeutics Plc | RNS |
| 21.04.2023 07:00 | AGY | FORM 8 (OPD) – Allergy Therapeutics plc | RNS |
| 20.04.2023 17:29 | AGY | Project Zebra Rule 2.9 Announcement | RNS |
| 19.04.2023 07:00 | AGY | Skin-prick testing completes in PROTECT Trial | RNS |
| 17.04.2023 14:30 | AGY | Form 8 OPD SkyGem Acquisition Limited Replacement | RNS |
| 17.04.2023 10:30 | AGY | Form 8 (OPD) SkyGem Acquisition Limited | RNS |
| 06.04.2023 14:42 | AGY | Allergy Therapeutics enters GBP41 million facility with ZQ Capital | Alliance |
| 06.04.2023 14:01 | AGY | £40.75 million Facility with Equity Financing | RNS |
| 06.04.2023 14:01 | AGY | Statement Regarding Possible Mandatory Cash Offer | RNS |
| 06.04.2023 14:00 | AGY | Trading and Business Update | RNS |
| 29.03.2023 07:00 | AGY | Publication of Interim Results Delayed | RNS |
| 27.03.2023 18:42 | NFX, TSTL, AGY | TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy | Alliance |
| 27.03.2023 07:00 | AGY | Patients dosed in VLP Peanut PROTECT trial | RNS |
| 08.03.2023 17:28 | AGY | Block Listing Interim Review | RNS |
| 03.03.2023 07:00 | AGY | PDMR Dealing | Reach |
| 07.02.2023 18:29 | AGY | Result of AGM | RNS |
| 20.01.2023 10:37 | AGY | Allergy Therapeutics revenue drops but optimistic about funding | Alliance |
| 20.01.2023 07:00 | AGY | Half-Year Trading Update 2023 | RNS |
| 13.01.2023 17:27 | AGY | NOTICE OF 2022 ANNUAL GENERAL MEETING | RNS |
| 03.01.2023 07:30 | AGY | Suspension - Allergy Therapeutics plc | RNS |
| 29.12.2022 11:05 | AGY | Second Price Monitoring Extn | RNS |
| 29.12.2022 11:00 | AGY | Price Monitoring Extension | RNS |
| 29.12.2022 09:26 | SML, TEK, AGY | AIM WINNERS & LOSERS: Allergy Therapeutics plunges as results delayed | Alliance |
| 29.12.2022 09:05 | AGY | Second Price Monitoring Extn | RNS |
| 29.12.2022 09:00 | AGY | Price Monitoring Extension | RNS |
| 29.12.2022 08:22 | AGY | Allergy Therapeutics shares halve as delayed audit to mean suspension | Alliance |
| 29.12.2022 07:00 | AGY | Annual Report and Accounts Delayed | RNS |
| 28.12.2022 07:00 | AGY | Director Resignation | RNS |
| 08.12.2022 11:07 | PANR, AGY, RCN | AIM WINNERS & LOSERS: Redcentric boasts "transformational" half-year | Alliance |
| 08.12.2022 11:04 | AGY | Allergy Therapeutics proffers peanut progress despite cost concerns | Alliance |
| 08.12.2022 07:00 | AGY | Key updates on Grass MATA MPL and VLP Peanut | RNS |
| 06.12.2022 07:00 | AGY | Appointment of Non-Executive Directors | RNS |
| 21.11.2022 17:00 | AGY | Allergy Therapeutics hires interim CFO as Nick Wykeman steps down | Alliance |
| 21.11.2022 07:00 | AGY | Appointment of Interim CFO | RNS |
| 28.10.2022 11:33 | DCTA, AGY, GGP | AIM WINNERS & LOSERS: Directa Plus wins deal; Greatland loss widens | Alliance |
| 28.10.2022 11:10 | NWG, AGY | IN BRIEF: Allergy Therapeutics resumes output; warns on revenue miss | Alliance |
| 28.10.2022 07:00 | AGY | Allergy to resume UK manufacturing production | RNS |
| 19.10.2022 15:39 | AGY | Holding(s) in Company | RNS |
| 17.10.2022 16:31 | KWG, AFRN, LEX | TRADING UPDATES: IQE, Trellus Health and Insig sign new agreements | Alliance |
| 17.10.2022 13:27 | AGY | Allergy Therapeutics – Result of GM | RNS |
| 04.10.2022 11:19 | AGY, WJG, N4P | AIM WINNERS & LOSERS: N4's Nuvec success; Watkin Jones tumbles | Alliance |
| 04.10.2022 10:35 | AGY | Allergy Therapeutics shares down as pauses production at UK facility | Alliance |
| 04.10.2022 10:15 | AGY | Allergy Therapeutics shares down as pauses production at UK facility | Alliance |
| 04.10.2022 07:00 | AGY | UK manufacturing update | RNS |
| 29.09.2022 22:08 | HAT, GMS, TGA | TRADING UPDATES: H&T plans raise; Joules turnaround continues | Alliance |
